[Retracted] Evaluation of ABC Bleeding Score and SAMe-TT2R2 Score on the Risk of Bleeding after Anticoagulation in Patients with Nonvalvular Atrial Fibrillation Complicated with Coronary Heart Disease

Table 1

The risk stratification distribution of two different scores (number of cases (%)).

Antithrombotic therapy	ABC bleeding score				SAMe-TT2R2 score
	Low-risk group (5 cases)	Intermediate risk group (83 cases)	High-risk group (61 cases)	value	£3 points (24 cases)	4 points (46 cases)	5 points (53 cases)	³6 points (26 cases)	Value
Anticoagulant therapy	2 (40.0)	25 (30.1)	18 (29.5)	0.886	5 (20.8)	13 (28.3)	14 (26.4)	13 (50.0)	0.099
Antiplatelet therapy	2 (40.0)	57 (68.7)	44 (72.1)	0.303	19 (79.2)	30 (65.2)	37 (69.8)	17 (65.4)	0.649
Nonantithrombotic therapy	1 (20.0)	5 (6.0)	4 (6.6)	0.431	1 (4.2)	4 (8.7)	4 (7.5)	1 (3.8)	0.910